Daye

U.K. femcare-turned-gynaecological-health startup, Daye, has expanded its tampon-based home screening service to add STI testing. The startup is billing this “non-invasive screening” service for sexually transmitted infections as a “world…

Daye now offers tampon-based STI screening — starting in the UK

U.K. women’s health Daye has a new string to its bow: It’s opened what it’s billing as the world’s first virtual period pain clinic. The new service, which extends the…

UK femtech Daye launches virtual clinic for period pain

Featured Article

Flush with Series A funding, Daye unwraps the big gynae health mission

Talking to Valentina Milanova, the still just 28-year-old founder of U.K. femtech Daye, is best described as an exhilarating experience. During our interview, she talks in and around her topic — building a startup supporting women’s sexual and reproductive health — non-stop for the best part of an hour, barely pausing for breath and without…

12:00 am PDT • October 26, 2022
Flush with Series A funding, Daye unwraps the big gynae health mission

Featured Article

Index Fund’s portfolio is driving long-overdue innovation in femcare

U.K. startup Daye is rethinking female intimate care from a woman’s perspective, starting with a tampon infused with cannabidiol that tackles period pain. It’s also quietly demolishing the retrograde approach to “femcare” product design that not only peddles stale and sexist stereotypes, but also can harm women’s bodies. Those perfumed sanitary pads stinking out the…

9:32 am PST • February 9, 2020
Index Fund’s portfolio is driving long-overdue innovation in femcare

Daye, a “femcare” startup developing a new type of tampon that uses CBD to help tackle dysmenorrhea, has quietly raised $5.5 million in funding from high-profile investors in the U.S.…

Daye, a startup developing a ‘cramp-fighting’ tampon, raises $5.5M from Khosla, Index and Kindred